Skip main navigation

  • pic1
  • pic2
  • pic3
  • pic4
  • pic5
  • pic6
  • pic7
  • pic8
  • pic9

Main contents starts here

Welcome to Takeda Ireland

Takeda Ireland Limited (TIL) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, a global research-based pharmaceutical company, the No 1 pharmaceutical company in Japan, and one of the world's top 100 companies.

Established in Ireland since 1997, Takeda employs over 400 people in the following areas: manufacturing of drug products (DP), active pharmaceutical ingredients (API), process development, packaging, supply chain, sales and marketing.

Takeda Ireland Ltd - Bray (DP)
TIL Bray, a wholly-owned subsidiary of Takeda Pharmaceutical Company has played a key role in Takeda's worldwide operations since being established in 1997. To date employing over 400 people and serving as the main pharmaceutical production base for blockbuster products to the European and U.S markets.

Takeda Ireland Ltd - Grange Castle (API, DP and Biologics)
In 2002 the first Takeda API (Active Pharmaceutical Ingredient) plant outside Japan was constructed in Clondalkin, Dublin 22, representing a key strategic addition to the group's global production network. The plant will is a launch vehicle for new strategic products for global markets developing and producing API's from clinical trial stages through to launch and full commercialisation.

In 2016 Grange Castle received planning approval to build a standalone high containment production facility dedicated to manufacturing our oncology product Ninlaro. The investment will create approximately 40 new jobs. Construction of the facility commenced in March 2017 with handover expected in August 2018 for production to start soon after. All steps of the production process including API, DP, primary and secondary packaging will be completed from Grange Castle for supply to global markets.

Grange Castle

In 2017 Grange Castle applied for planning permission for the construction of a new biologics facility. Construction of the facility is planned to commence in April 2018 with production start scheduled in 2019.

Grange Castle

Takeda Products Ireland (TPI)
Based in Citywest, Takeda Products Ireland Limited was established to market Takeda's products throughout the Republic of Ireland. Takeda Products Ireland Limited is dedicated to improving Irish patients' lives by bringing to the market, new and better medicines, developed by Takeda and key partners, to help address the nation's most pressing healthcare needs.
For more information about TPI please click here.

Skip side navigation


Skip sub navigation

Page Top